What amount sold does IMAGINEERING TECHNOLOGIES INC report in Form D filings?

The latest linked filings report $0 sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was IMAGINEERING TECHNOLOGIES INC's most recent SEC filing?

IMAGINEERING TECHNOLOGIES INC's most recent Form D filing was on 2016-07-25.

What type of securities does IMAGINEERING TECHNOLOGIES INC offer?

IMAGINEERING TECHNOLOGIES INC's SEC Form D filings indicate equity offerings.

IMAGINEERING TECHNOLOGIES INC

CIK: 0001158417·Pharmaceuticals·IDAHO FALLS, ID·Corporation

Reported Sold

Total Filings

Identified Offerings

Last Filed

Jul 25, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Jul 25, 2016Form D — New notice

Reported sold: $0 · Target: $14,000,000

Rule 506(c)·0 investors

Jul 25, 2016Form D/A — Amendment

Reported sold: $0 · Target: $14,000,000

Rule 506(c)·0 investors

Mar 5, 2010Form D — New notice

Reported sold: $0 · Target: $14,000,000

Rule 506·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Henry Makowitz

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold
Jul 25, 2016	New	$14,000,000	$0
Jul 25, 2016	Amendment	$14,000,000	$0
Mar 5, 2010	New	$14,000,000	$0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

EIKONOKLASTES THERAPEUTICS, INC.

Pharmaceuticals

Offering target: $18,638,880

Filed Oct 5, 2026